Form 4 Filing for Henderson Jane at Apogee Therapeutics, Inc.

This filing details a transaction by Henderson Jane, Chief Financial Officer of Apogee Therapeutics, Inc. (APGE). On April 16, 2026, Ms. Henderson disposed of 2,000 shares of Common Stock at a price of $90.00 per share. This sale was executed under a Rule 10b5-1 trading plan adopted on September 2, 2025. Following this transaction, Ms. Henderson directly owns 175,371 shares of Apogee Therapeutics, Inc. stock. The filing was made on April 17, 2026.